Search Results - "Furuse, Junji"

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines by Okusaka, Takuji, Furuse, Junji

“…The prognosis of patients with pancreatic cancer continues to remain dismal, even though numerous trials have been conducted to establish more effective…”
Get full text

Chemotherapy for hepatocellular carcinoma: current status and future perspectives by Ikeda, Masafumi, Morizane, Chigusa, Ueno, Makoto, Okusaka, Takuji, Ishii, Hiroshi, Furuse, Junji

“…The present status and future perspectives of chemotherapy, including first-line and second-line systemic chemotherapy and hepatic arterial infusion…”
Get full text

First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors by Okano, Naohiro, Naruge, Daisuke, Kawai, Kirio, Kobayashi, Takaaki, Nagashima, Fumio, Endou, Hitoshi, Furuse, Junji

“…Summary This open-label first-in-human study evaluated JPH203, which is a novel selective L-type amino acid transporter 1 inhibitor. We also evaluated the…”
Get full text

Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition by Nagino, Masato, Hirano, Satoshi, Yoshitomi, Hideyuki, Aoki, Taku, Uesaka, Katsuhiko, Unno, Michiaki, Ebata, Tomoki, Konishi, Masaru, Sano, Keiji, Shimada, Kazuaki, Shimizu, Hiroaki, Higuchi, Ryota, Wakai, Toshifumi, Isayama, Hiroyuki, Okusaka, Takuji, Tsuyuguchi, Toshio, Hirooka, Yoshiki, Furuse, Junji, Maguchi, Hiroyuki, Suzuki, Kojiro, Yamazaki, Hideya, Kijima, Hiroshi, Yanagisawa, Akio, Yoshida, Masahiro, Yokoyama, Yukihiro, Mizuno, Takashi, Endo, Itaru

“…Background The Japanese Society of Hepato‐Biliary‐Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers…”
Get full text

Treatments for elderly cancer patients and reforms to social security systems in Japan by Nagashima, Fumio, Furuse, Junji

“…In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is…”
Get full text

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05) by Motoi, Fuyuhiko, Kosuge, Tomoo, Ueno, Hideki, Yamaue, Hiroki, Satoi, Sohei, Sho, Masayuki, Honda, Goro, Matsumoto, Ippei, Wada, Keita, Furuse, Junji, Matsuyama, Yutaka, Unno, Michiaki

“…A randomized, controlled trial has begun to compare neoadjuvant chemotherapy using gemcitabine and S-1 with upfront surgery for patients planned resection of…”
Get more information

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial by Yau, Thomas, Park, Joong-Won, Finn, Richard S, Cheng, Ann-Lii, Mathurin, Philippe, Edeline, Julien, Kudo, Masatoshi, Harding, James J, Merle, Philippe, Rosmorduc, Olivier, Wyrwicz, Lucjan, Schott, Eckart, Choo, Su Pin, Kelley, Robin Kate, Sieghart, Wolfgang, Assenat, Eric, Zaucha, Renata, Furuse, Junji, Abou-Alfa, Ghassan K, El-Khoueiry, Anthony B, Melero, Ignacio, Begic, Damir, Chen, Gong, Neely, Jaclyn, Wisniewski, Tami, Tschaika, Marina, Sangro, Bruno

“…Single-agent nivolumab showed durable responses, manageable safety, and promising survival in patients with advanced hepatocellular carcinoma in the phase 1–2…”
Get full text

Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer by Furuse, Junji, Shibahara, Junji, Sugiyama, Masanori

“…While surgery currently remains the only potentially curative treatment available for pancreatic cancer, only 20% to 30% of patients have resectable disease at…”
Get full text

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system by Yamaguchi, Tomohiro, Machida, Nozomu, Morizane, Chigusa, Kasuga, Akiyoshi, Takahashi, Hideaki, Sudo, Kentaro, Nishina, Tomohiro, Tobimatsu, Kazutoshi, Ishido, Kenji, Furuse, Junji, Boku, Narikazu, Okusaka, Takuji

“…This study analyzed outcomes of systemic chemotherapy for advanced neuroendocrine carcinoma (NEC) of the digestive system. Clinical data from 258 patients with…”
Get full text

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies by Nakamura, Yoshiaki, Taniguchi, Hiroya, Ikeda, Masafumi, Bando, Hideaki, Kato, Ken, Morizane, Chigusa, Esaki, Taito, Komatsu, Yoshito, Kawamoto, Yasuyuki, Takahashi, Naoki, Ueno, Makoto, Kagawa, Yoshinori, Nishina, Tomohiro, Kato, Takeshi, Yamamoto, Yoshiyuki, Furuse, Junji, Denda, Tadamichi, Kawakami, Hisato, Oki, Eiji, Nakajima, Takako, Nishida, Naohiro, Yamaguchi, Kensei, Yasui, Hisateru, Goto, Masahiro, Matsuhashi, Nobuhisa, Ohtsubo, Koushiro, Yamazaki, Kentaro, Tsuji, Akihito, Okamoto, Wataru, Tsuchihara, Katsuya, Yamanaka, Takeharu, Miki, Izumi, Sakamoto, Yasutoshi, Ichiki, Hiroko, Hata, Masayuki, Yamashita, Riu, Ohtsu, Atsushi, Odegaard, Justin I., Yoshino, Takayuki

“…Comprehensive genomic profiling enables genomic biomarker detection in advanced solid tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA)…”
Get full text

New developments in systemic therapy for advanced biliary tract cancer by Morizane, Chigusa, Ueno, Makoto, Ikeda, Masafumi, Okusaka, Takuji, Ishii, Hiroshi, Furuse, Junji

“…Biliary tract cancer, carcinoma of the extrahepatic bile ducts, carcinoma of the gall bladder, ampullary carcinoma and intrahepatic cholangiocarcinoma are…”
Get more information

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective by Venook, Alan P., Papandreou, Christos, Furuse, Junji, Ladrón de Guevara, Laura

“…Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death worldwide, and the burden of this devastating cancer is expected to increase further…”
Get full text

Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan by Furuse, Junji

“…Systemic chemotherapy plays an important role in the treatment of pancreatic cancer, to improve the survival of patients with pancreatic cancer. Unresectable…”
Get full text

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines) by Hasegawa, Kiyoshi, Takemura, Nobuyuki, Yamashita, Tatsuya, Watadani, Takeyuki, Kaibori, Masaki, Kubo, Shoji, Shimada, Mitsuo, Nagano, Hiroaki, Hatano, Etsuro, Aikata, Hiroshi, Iijima, Hiroko, Ueshima, Kazuomi, Ohkawa, Kazuyoshi, Genda, Takuya, Tsuchiya, Kaoru, Torimura, Takuji, Ikeda, Masafumi, Furuse, Junji, Akahane, Masaaki, Kobayashi, Satoshi, Sakurai, Hideyuki, Takeda, Atsuya, Murakami, Takamichi, Motosugi, Utaroh, Matsuyama, Yutaka, Kudo, Masatoshi, Tateishi, Ryosuke

“…The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology…”
Get full text

Efficacy and safety of systemic treatments using immune checkpoint inhibitors for advanced hepatocellular carcinoma by Furuse, Junji

Get more information

Management of elderly patients with unresectable pancreatic cancer by Kobayashi, Satoshi, Ueno, Makoto, Ishii, Hiroshi, Furuse, Junji

“…Systemic chemotherapy plays important role in pancreatic cancer not only for palliative treatment of unresectable disease, but also for neoadjuvant and…”
Get more information

Systemic therapy for hepatocellular carcinoma: current status and future perspectives by Furuse, Junji, Ueno, Makoto, Ikeda, Masafumi

“…Since sorafenib was established as the standard of care for patients with advanced hepatocellular carcinoma, various tyrosine kinase inhibitors, targeting…”
Get more information

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study by Marrero, Jorge A., Kudo, Masatoshi, Venook, Alan P., Ye, Sheng-Long, Bronowicki, Jean-Pierre, Chen, Xiao-Ping, Dagher, Lucy, Furuse, Junji, Geschwind, Jean-Francois H., de Guevara, Laura Ladrón, Papandreou, Christos, Takayama, Tadatoshi, Sanyal, Arun J., Yoon, Seung Kew, Nakajima, Keiko, Lehr, Robert, Heldner, Stephanie, Lencioni, Riccardo

“…[Display omitted] GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) is a prospective,…”
Get full text

Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials by Nara, Satoshi, Esaki, Minoru, Ban, Daisuke, Takamoto, Takeshi, Shimada, Kazuaki, Ioka, Tatsuya, Okusaka, Takuji, Ishii, Hiroshi, Furuse, Junji

“…Cancer originating in the biliary tract can be classified as bile duct cancer (cholangiocarcinoma), gallbladder cancer, or ampullary cancer. Bile duct cancer…”
Get more information

Stereotactic body radiotherapy plus pembrolizumab and trametinib for pancreatic cancer by Okano, Naohiro, Mizutani, Tomonori, Nagashima, Fumio, Furuse, Junji

Get full text